leisure time -WSS

leisure time

author：fashion 2025-09-30 00:50:31 - browse：3169

Scanned cerebellum of a mouse brain, affected by Niemann-Pick Type C, shown in pink and teal — biotech coverage from STAT — The cerebellum of a mouse brain affected by Niemann-Pick Type C. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health

About a decade ago, Tatiana Bremova-Ertl’s graduate adviser was studying an obscure, 1950s-era French vertigo drug, probing its effects on people with balance disorders, when she thought of another, very sick group of patients.

A graduate student and medical resident at the German Center for Vertigo and Balance Disorders, in Munich, Bremova-Ertl often saw patients with Niemann-Pick Type C, a rare, genetic disease that slowly kills neurons.

NPC has a range of manifestations. When symptoms appear in early childhood, it is often fatal before adulthood. When it manifests later, it can be milder. But it’s always degenerative and leads to a cluster of challenges: cognitive decline, difficulty with speech and swallowing, enlarged liver, low muscle tone, and, notably, difficulty with balance and muscle control. Researchers and a fervent group of parents were working to develop medicines, but little had yet worked.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Weighted lottery helped low

WSS

FDA approves Recor Medical high blood pressure device

The (many) problems with a new study criticizing cancer screening

Medicare will require more price transparency from hospitals

UCSF medical school apologizes for unethical prisoner experiments

Medicaid rebukes states for mistakenly disenrolling children

Will General Catalyst be the first of many hospital takeovers?

hotspot

leisure time

focus

Novavax promises a turnaround & Lilly roils the obesity market

Excited delirium, Elijah McClain, and emergency physicians

Medical leaders decry Supreme Court decision on affirmative action

ALS advocates say criticism of new drugs misses bigger picture

Heart attack and stroke risk calculators need revising

10 million people disenrolled from Medicaid over past six months

Jerome Adams on the need for new antivirals for Covid

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

23andMe had bad news about my health. I wish a person had delivered it

Humana sues Biden admin over Medicare Advantage audit rule

hotspot

A clever new way to fix Medicaid and graduate medical education

Just how powerful is the placebo effect?

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Why Novartis is changing the name of its research labs

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Trump surgeon general acknowledges mistakes during Covid

explore

explore

Wikipedia

focus